Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
Quick Stats
Jul 02, 202651.1
AI Score
HOLD0.62
Volume Ratio
Aug 13, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
OMER Stock Summary
Last updated Jul 02, 2026
OMER is currently trading at $9.28, positioned below its 200-day moving average of $10.37, suggesting bearish momentum. The stock has a 52-week range of $2.96 to $17.65.
Technical Analysis: The 50-day moving average stands at $11.77, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.966, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.236, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates OMER at 51.1/100 with a HOLD recommendation.
OMER (Omeros Corporation) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.966 |
| CMF (20) | 0.236 |
| ROC (10) | -3.734 |
| ADX (14) | 38.486 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.492 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -37.598 |
| MFI (14) | 49.668 |
OMER Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
OMER Price vs Max Options Open Interest
OMER Max Change In Options Open Interest
OMER Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OMER Daily Out of Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OMER Daily In the Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
OMER Most Active Options by Volume(near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Omeros Corporation is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
OMER Moving Averages Analysis
OMER (Omeros Corporation) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 9.92 |
| 20 | 9.83 |
| 30 | 10.28 |
| 50 | 11.77 |
| 100 | 11.62 |
| 200 | 10.37 |
OMER Fundamental Analysis
| P/E (Forward) | 58.1395 |
| P/E (Trailing) | 8.2544 |
| Market Cap ($) | 681.1 million |
| Earnings/Share ($) | 1.14 |
| Net Proft Margin (%) | 8.7102 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.38 |
| EPS Estimate Next Year ($) | -0.155 |
| WallStreet Target Price ($) | 33 |
| Most Recent Quarter |
Short squeeze confirmed for OMER stock as it reaches $16.50, with expectations to hit $20. Investors advised to hold and not panic sell despite shorts trying to influence. More inflow expected for OMER stock.
Updated 2025-12-29 17:00:01